MML Investors Services LLC Increases Investment in IQVIA Holdings Inc.

MML Investors Services LLC has increased its investment in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 6.3% in the third quarter, as indicated by its latest filing with the SEC. After acquiring an additional 7,980 shares, the firm now holds a total of 134,396 shares in the medical research company. At the close of the most recent quarter, MML Investors Services LLC's stake in IQVIA was valued at approximately $31,848,000, which represents about 0.07% of the company’s total shares.

Additionally, other institutional investors have made changes to their holdings in the company. For instance, Tenere Capital LLC purchased a new stake in IQVIA during the third quarter, amounting to approximately $14,896,000. Meanwhile, Orion Portfolio Solutions LLC raised its investment in IQVIA by 2.3% during the same period, bringing their total to 16,319 shares worth about $3,867,000 after adding 364 shares to their position. Similarly, iSAM Funds UK Ltd increased its stake by 28.3%, now owning 2,576 shares with a value of $610,000 after acquiring an additional 568 shares. In a significant move, National Bank of Canada FI saw its investments in IQVIA grow by 245.0%, now holding 181,423 shares valued at $42,992,000 after acquiring 128,843 more shares during the last quarter. Voya Financial Advisors Inc. also raised its standing by 0.6%, accumulating 12,272 shares with a valuation of $2,881,000 after purchasing an extra 73 shares. Overall, hedge funds and other institutional investors are major shareholders, owning 89.62% of IQVIA's stock.

Recent Stock Performance

The stock began trading at $202.63 on Monday. IQVIA has a market capitalization of $36.78 billion, with a price-to-earnings (P/E) ratio of 26.59 and a price-to-earnings-growth ratio of 2.08. It also has a beta of 1.49, reflecting volatility in comparison to the market. The company reports a debt-to-equity ratio of 1.76 along with quick and current ratios both standing at 0.81. Over the past year, IQVIA has seen a low of $187.62 and a high of $261.73, with its 50-day simple moving average at $215.18 and its 200-day simple moving average at $225.10.

Analyst Ratings and Market Insights

Several research firms have recently analyzed the shares of IQVIA. Morgan Stanley lowered its target price for IQVIA from $280.00 to $265.00 while maintaining an "overweight" rating on the stock, as stated in a research report on November 4th. Truist Financial also adjusted their target to $265.00 from $286.00, reiterating a "buy" rating. StockNews.com downgraded the stock from a "buy" to a "hold" rating in a report published on November 28th. Further, Evercore ISI lowered its price objective from $270.00 to $265.00 while continuing to rate it as "outperform" on October 8th. Lastly, Royal Bank of Canada confirmed its "outperform" stance and set a target price of $270.00 on IQVIA shares. According to MarketBeat.com, a total of five analysts have rated the stock as a hold, fourteen as a buy, and one as a strong buy, leading to an average rating of "Moderate Buy" and a consensus price target of $256.50.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is engaged in providing advanced analytics, technology solutions, and clinical research services to the life sciences sector across the Americas, Europe, Africa, and the Asia-Pacific region. The company operates through three primary segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

investment, stocks, IQVIA